Market Access

Ortheia’s companies have direct access to the UK orthopaedic implant market through JRI Orthopaedics' Sales Team and market access through agents and distributors across the rest of the world including elsewhere in the EU, USA, Australia, Brazil and China.

This market access is crucial to support First in Human Studies, and can also develop into an initial launch with design surgeons and/or early adopters. After this point, a commercial agreement with JRI Orthopaedics can be set up to sell your product.